Physician
Cripps, Hooper & Rhody, PLLC
Cripps, Hooper & Rhody, PLLC was paid $1.00M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 69% of everything it billed.
33Billing provider infoCRIPPS, HOOPER & RHODY, PLLC
SMITHVILLE, TN 37166
SMITHVILLE, TN 37166
33aNPI1679677199assigned 09/13/2006
33bProvider typeFamily Medicine Physician
28Total paid$1.00M
24GClaims51,000
24DCodes billed50
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Tennessee
Rank by total paid#57 of 754
Median peer was paid$34K
This provider vs. median30×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,371 | $157K | |
| 2019 | 8,654 | $145K | |
| 2020 | 7,823 | $140K | |
| 2021 | 7,404 | $180K | |
| 2022 | 6,627 | $157K | |
| 2023 | 6,657 | $133K | |
| 2024incomplete | 3,464 | $89K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 69% | 21,377 | 18,722 | $689K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 11% | 1,069 | 915 | $114K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 3,439 | 2,986 | $102K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.9% | 341 | 324 | $19K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.4% | 1,557 | 1,328 | $14K |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 11,003 | 9,312 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,432 | 2,971 | $9K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 390 | 340 | $8K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 244 | 195 | $7K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 292 | 266 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 342 | 264 | $4K |
| 90682 | <1% | 140 | 97 | $3K |
38 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 291 | $2K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 26 | $2K |
| 90688 | <1% | 225 | $2K | |
| 87400 | <1% | 166 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 159 | $1K |
| 1159F | <1% | 946 | $1K | |
| 81001 | <1% | 1,088 | $953.56 | |
| 3074F | <1% | 476 | $950.82 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 83 | $803.86 |
| 3008F | <1% | 324 | $770.00 | |
| 80053 | Comprehensive metabolic panel | <1% | 1,248 | $689.93 |
| 3078F | <1% | 449 | $664.08 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 34 | $332.13 |
| 80061 | Lipid panel | <1% | 641 | $247.28 |
| G0008 | Administration of influenza virus vaccine | <1% | 242 | $148.82 |
| 90756 | <1% | 14 | $123.55 | |
| 1160F | <1% | 28 | $90.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 115 | $54.95 |
| 3079F | <1% | 30 | $50.00 | |
| 3077F | <1% | 14 | $40.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 58 | $35.10 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 45 | $13.11 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 16 | $0.00 |
| 1030F | 0% | 42 | $0.00 | |
| 1022F | 0% | 30 | $0.00 | |
| 1125F | 0% | 77 | $0.00 | |
| 1036F | 0% | 68 | $0.00 | |
| 1101F | 0% | 40 | $0.00 | |
| 1170F | 0% | 91 | $0.00 | |
| 91301 | 0% | 21 | $0.00 | |
| 3017F | 0% | 31 | $0.00 | |
| 4037F | 0% | 18 | $0.00 | |
| 3048F | 0% | 13 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 16 | $0.00 |
| 2022F | 0% | 15 | $0.00 | |
| 90662 | 0% | 146 | $0.00 | |
| 1090F | 0% | 34 | $0.00 | |
| 3725F | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARTIN, MICHIKO (OFFICE MANAGER)